Vanguard Portfolio Management
MIRM icon

Vanguard Portfolio Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Vanguard Portfolio Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$278M Buy
2,377,019
+944,936
+66% +$94.9M 0.01% 1029
2026
Q1 		$132M Buy
+1,432,083
New +$135M 0.01% 1333

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management's MIRM Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Mirum Pharmaceuticals (MIRM) stake by 66% in Q2 2026, buying an estimated $94.9M and bringing the position to 2,377,019 shares worth $278M. The position accounts for 0.01% of the portfolio, ranked #1029.

Vanguard Portfolio Management first reported a position in MIRM in Q1 2026 and has held it in 2 quarters since. 326 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Vanguard Portfolio Management held 2,377,019 shares of Mirum Pharmaceuticals worth $278M as of Q2 2026.
  • Vanguard Portfolio Management bought 944,936 Mirum Pharmaceuticals shares in Q2 2026, an estimated $94.9M.
  • Mirum Pharmaceuticals made up 0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #1029 holding.
  • Vanguard Portfolio Management first reported a position in Mirum Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 326 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.